National Perox.

Why is National Peroxide Ltd falling/rising?

As of 19-Jun, National Peroxide Ltd's stock price is at 565.05, down 3.08% after a trend reversal. Despite a strong year-to-date gain of 20.74%, the stock has underperformed recently, contributing to current downward pressure.

As of 19-Jun, National Peroxide Ltd's stock price is falling, currently at 565.05, which represents a decrease of 17.95 or 3.08%. This decline follows a trend reversal after three consecutive days of gains. The stock has underperformed its sector by 4.09% today, indicating weaker performance relative to its peers. <BR><BR>In terms of intraday movements, the stock reached a high of Rs 594.9 but fell to a low of Rs 560, reflecting significant volatility within the trading day. Additionally, the weighted average price suggests that more volume was traded closer to the low price, which may indicate selling pressure. <BR><BR>Over the past month, the stock has experienced a notable decline of 7.42%, contrasting with a positive return of 2.13% for the Sensex during the same period. Year-to-date, however, the stock has shown a strong performance with a gain of 20.74%, while the Sensex has decreased by 9.88%. Despite this positive year-to-date performance, the stock has a one-year decline of 16.97%, which may contribute to investor sentiment and the current downward movement. <BR><BR>Overall, the combination of recent underperformance, volatility, and a significant drop today suggests that National Peroxide Ltd's stock is currently facing downward pressure.

Which are the latest news on National Perox.?

What does National Perox. do?

National Peroxide Ltd, a micro-cap company in the commodity chemicals industry, reported net sales of 86 Cr and a net profit of 8 Cr for the quarter ending March 2026. The company has a market cap of INR 314 Cr and a P/E ratio of 27.00.

Overview:<BR>National Peroxide Ltd operates in the commodity chemicals industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 2020 as NPL Chemicals Limited and underwent a name change to National Peroxide Limited through a Composite Scheme of Arrangement. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 86 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 8 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 314 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 27.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.16 <BR>Return on Equity: 3.21% <BR>Price to Book: 0.87 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is National Perox.?

As of 10th June, National Peroxide Ltd has a market capitalization of 314.00 Cr, with recent net sales of 289.72 Cr and a net profit of 11.04 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: National Peroxide Ltd has a market capitalization of 314.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 289.72 Cr, while the sum of Net Profit for the same period is 11.04 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 349.26 Cr, and Total Assets amount to 441.72 Cr.

Who are the peers of the National Perox.?

National Perox.'s peers include Andhra Petrochem, Lords Chloro, Kanoria Chem., Mangalam Organic, Alufluoride, Hind.Organ.Chem., Genus Prime, ZR2 Bioenergy, and Kesar Petroprod. Alufluoride leads in 1-year returns at 14.28%, while National Perox. has a return of -24.01%.

Peers: The peers of National Perox. are Andhra Petrochem, Lords Chloro, Kanoria Chem., Mangalam Organic, Alufluoride, Hind.Organ.Chem., Genus Prime, ZR2 Bioenergy, and Kesar Petroprod.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride, while Average management risk is found at Andhra Petrochem, Lords Chloro, Mangalam Organic, and Kesar Petroprod., and the rest have Below Average management risk. Good growth is noted at Alufluoride, Lords Chloro, and Genus Prime, while Below Average growth is seen at Kanoria Chem., Mangalam Organic, and National Perox., and the rest have Below Average growth. Excellent capital structure is present at Andhra Petrochem, while Good capital structure is noted at National Perox. and Alufluoride, Average capital structure is found at Lords Chloro, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Alufluoride at 14.28%, while the lowest is ZR2 Bioenergy at -68.86%. National Perox.'s 1-year return of -24.01% is worse than Alufluoride's but better than ZR2 Bioenergy's. Additionally, ZR2 Bioenergy and Kesar Petroprod. have negative six-month returns.

Should I buy, sell or hold National Peroxide Ltd?

When is the next results date for National Peroxide Ltd?

The next results date for National Peroxide Ltd is April 30, 2026.

The next results date for National Peroxide Ltd is scheduled for April 30, 2026.

Are National Peroxide Ltd latest results good or bad?

National Peroxide Ltd's latest Q3 FY26 results show a significant net profit increase of 369.23% quarter-on-quarter and improved revenue, but concerns remain due to a history of losses, low return on equity, and a 40.21% decline in stock value over the past year, indicating mixed overall performance. Caution is advised regarding the company's future prospects.

National Peroxide Ltd's latest results for Q3 FY26 present a mixed picture. On one hand, the company reported a net profit of ₹1.83 crore, which is a significant improvement of 369.23% quarter-on-quarter. Additionally, revenue increased by 1.17% from the previous quarter, reaching ₹69.09 crore, and this marks an 11.15% increase year-on-year.<BR><BR>The operating margin also improved to 10.12%, the highest in seven quarters, suggesting some operational stability. However, this recovery comes after a challenging FY25, where the company faced a net loss of ₹2 crore on revenues of ₹286 crore, indicating a significant decline from a profit of ₹16 crore in FY24.<BR><BR>Despite these positive indicators, the overall financial health of National Peroxide remains concerning. The company has struggled with volatile margins, and its return on equity (ROE) is alarmingly low at 1.90%, with the latest quarterly ROE even dipping to -1.92%. The stock has underperformed significantly, with a one-year decline of 40.21%, contrasting sharply with the broader market's performance.<BR><BR>In summary, while there are some signs of recovery in the most recent quarter, the underlying issues, including poor historical performance and low investor confidence, suggest that the results are not entirely positive. Caution is warranted when assessing the company's future prospects.

How has been the historical performance of National Perox.?

National Perox has experienced a significant decline in financial performance over the past three years, with net sales dropping from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, resulting in a loss of -2.25 Cr in profit after tax. Key metrics such as operating profit and earnings per share also fell sharply, indicating reduced profitability and cash generation capabilities.

Answer:<BR>The historical performance of National Perox shows a decline in key financial metrics over the past three years, culminating in a loss for the year ending March 2025.<BR><BR>Breakdown:<BR>National Perox's net sales decreased from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, reflecting a downward trend in total operating income, which also fell from 375.87 Cr to 286.87 Cr during the same period. The company's total expenditure, excluding depreciation, decreased from 317.36 Cr in March 2023 to 271.66 Cr in March 2025, primarily due to a reduction in raw material costs from 191.26 Cr to 145.46 Cr. However, operating profit (PBDIT) declined significantly from 67.36 Cr in March 2023 to 19.70 Cr in March 2025, leading to a profit before tax of -2.08 Cr in March 2025, down from 53.50 Cr in March 2023. Consequently, profit after tax also turned negative, reaching -2.25 Cr in March 2025 compared to 39.50 Cr in March 2023. The company's earnings per share (EPS) reflected this downturn, dropping from 68.7 in March 2023 to -3.91 in March 2025. On the balance sheet, total liabilities decreased from 453.55 Cr in March 2023 to 441.72 Cr in March 2025, while total assets also fell from 453.55 Cr to 441.72 Cr. Cash flow from operating activities showed a decline from 67.00 Cr in March 2023 to 18.00 Cr in March 2025, indicating a significant reduction in cash generation capabilities. Overall, National Perox's financial performance has deteriorated over the past three years, resulting in losses and reduced profitability.

Who are the top shareholders of the National Perox.?

The top shareholders of National Perox include Nowrosjee Wadia And Sons Limited with 30.78% and individual investors with 24.82%. There are no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of National Perox include the promoters, with Nowrosjee Wadia And Sons Limited holding the largest stake at 30.78%. Additionally, individual investors collectively hold 24.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

Is National Perox. overvalued or undervalued?

As of May 7, 2025, National Perox. is considered overvalued and risky, with a PE ratio of -157.63 and negative EV ratios, indicating poor financial performance compared to peers like Solar Industries and Godrej Industries, despite a recent stock return of 8.61%.

As of 7 May 2025, the valuation grade for National Perox. has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued. Key ratios highlight this concern: the PE ratio stands at an alarming -157.63, while the EV to EBIT ratio is also negative at -64.72, and the EV to EBITDA ratio is at 20.91. These figures suggest that the company is struggling to generate profits relative to its valuation.<BR><BR>In comparison to its peers, National Perox. shows stark contrasts. For instance, Solar Industries India Ltd. has a PE ratio of 123.77, while Godrej Industries Ltd. boasts a PE ratio of 46.63, both indicating much stronger valuations. Additionally, National Perox.'s ROE is at -0.63%, further emphasizing its underperformance relative to the industry. Despite a recent stock return of 8.61% over the past week, which outperformed the Sensex's 1.35%, the overall financial metrics suggest that investors should approach National Perox. with caution.

What is the technical trend for National Perox.?

As of June 6, 2025, National Perox's technical trend has shifted to a moderate bearish stance, indicated by daily moving averages and weekly KST readings, despite some mixed signals from the Dow Theory and weekly MACD.

As of 6 June 2025, the technical trend for National Perox has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators include the daily moving averages showing a mildly bearish trend, while the weekly KST is bearish. The Dow Theory indicates a mildly bullish stance on the weekly but remains bearish on the monthly, suggesting mixed signals. The MACD on the weekly is mildly bullish, but the overall sentiment leans bearish due to the prevailing moving averages and KST readings.

Has National Perox. declared dividend?

Yes, National Peroxide Ltd has declared a 125% dividend, amounting to ₹12.5 per share, with an ex-date of August 20, 2024. However, the company's total returns have been negative in the last 6 months and stagnant over the past several years.

National Peroxide Ltd has declared a 125% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 125%<BR>- Amount per share: 12.5<BR>- Ex-date: 20 Aug 24<BR><BR>Dividend Yield: 2.05%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.82%, the dividend return was 0%, resulting in a total return of -30.82%.<BR><BR>Over the past year, there was no price return, no dividend return, leading to a total return of 0.0%.<BR><BR>In the 2-year period, the price return remained at 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>For the 3-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there was a price return of 0%, no dividend return, leading to a total return of 0.0%.<BR><BR>Finally, in the 5-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while National Peroxide Ltd has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the short term with a notable decline in price return.